GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PixarBio Corp (GREY:PXRB) » Definitions » EV-to-EBITDA

PixarBio (PixarBio) EV-to-EBITDA : 0.00 (As of Jun. 19, 2024)


View and export this data going back to 2016. Start your Free Trial

What is PixarBio EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, PixarBio's enterprise value is $0.00 Mil. PixarBio's EBITDA for the trailing twelve months (TTM) ended in Sep. 2016 was $-0.15 Mil. Therefore, PixarBio's EV-to-EBITDA for today is 0.00.

The historical rank and industry rank for PixarBio's EV-to-EBITDA or its related term are showing as below:

PXRB's EV-to-EBITDA is not ranked *
in the Biotechnology industry.
Industry Median: 8.71
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-19), PixarBio's stock price is $1.0E-5. PixarBio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2016 was $0.000. Therefore, PixarBio's PE Ratio for today is N/A.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


PixarBio EV-to-EBITDA Historical Data

The historical data trend for PixarBio's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PixarBio EV-to-EBITDA Chart

PixarBio Annual Data
Trend Dec14 Dec15
EV-to-EBITDA
- -

PixarBio Quarterly Data
Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PixarBio's EV-to-EBITDA

For the Biotechnology subindustry, PixarBio's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PixarBio's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PixarBio's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where PixarBio's EV-to-EBITDA falls into.



PixarBio EV-to-EBITDA Calculation

PixarBio's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.000/-0.149
=0.00

PixarBio's current Enterprise Value is $0.00 Mil.
PixarBio's EBITDA for the trailing twelve months (TTM) ended in Sep. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PixarBio  (GREY:PXRB) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

PixarBio's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.0E-5/0.000
=N/A

PixarBio's share price for today is $1.0E-5.
PixarBio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


PixarBio EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of PixarBio's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


PixarBio (PixarBio) Business Description

Traded in Other Exchanges
N/A
Address
200 Boston Avenue, Suite 1875, Medford, MA, USA, 02155
PixarBio Corp is a specialty pharmaceutical company focused on preclinical and clinical commercial development of therapeutic drug delivery systems for post-operative pain. The company's lead clinical candidate, NeuroRelease is a non-opioid / non-opiate preclinical stage product intended for the treatment of surgical pain, with planned future indications for chronic pain. NeuroRelease blocks nociceptive and neuropathic pain signals arising from temperature and pressure stimuli without affecting motor function, which is intended to allow for effective treatment without delaying post-surgical physical therapy.

PixarBio (PixarBio) Headlines